Kaken Pharmaceutical Co.,Ltd.

Character size

S
M
L

JPN
ENG

Contact Us

About Kaken
About Kaken TOP
Business
Business TOP
Investor Relations
Investor Relations TOP
Press Release

About Kaken
Business
Investor Relations
Press Release

View All

April 27, 2022Notice on KP-607, a Treatment for Onychomycosis
March 29, 2022Announcement on Recording of Extraordinary Losses and Revisions to the Full-year Earnings Forecast
December 13, 2021Kaken Completes Acquisition of ARTham Therapeutics Inc.
November 30, 2021Notice on Acquisition of ARTham Therapeutics Inc.

KAKEN PHARMACEUTICAL CO.,LTD.
2-28-8 Honkomagome, Bunkyo-ku, Tokyo, 113-8650, Japan

JPN
ENG

Contact Us

About Kaken

Company Profile
Corporate Governance
History
Compliance
Environmental Initiatives
Map

Business

Pharmaceuticals and Medical Devices
Agrochemicals and Animal Health Products
Overseas Activity
Research & Development Division
Licensing Opportunities

Investor Relations

Consolidated Earnings Briefing
Consolidated Financial Results
Corporate Report
Shareholders' Meeting
Disclosure Policy

Press Release

Site Map

Personal Information Protection Policy
Handling of Personal Information at the KAKEN Website
Terms of Use

Social Media Guidelines

© KAKEN PHARMACEUTICAL CO., LTD.